Literature DB >> 3120406

Neuron-specific enolase and malignant lymphomas (23 cases).

J Nemeth1, A Galian, J Mikol, B Cochand-Priollet, M Wassef, A Lavergne.   

Abstract

The immunoreactivity of polyclonal antiserum to neuron-specific enolase (NSE) has been investigated. Twenty-three cases of malignant lymphoma (ML) were studied and compared with previously published reports. In our study 11 out of 23 cases showed strong or weak NSE positivity; any type of ML could be positive or negative even among B or T cell ML. This study indicated that polyclonal NSE is not a specific marker; it might be an inconstant marker of ML with no apparent correlation between reactivity and morphology or phenotype.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3120406     DOI： 10.1007/bf00750736

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN： 0174-7398


  21 in total

1.  Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells.

Authors:  D Schmechel; P J Marangos; M Brightman
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  In situ immunologic characterization of follicular lymphomas.

Authors:  E Ancelin; G Delsol; J Familiades; D Y Mason; E Kuhlein; T Al Saati; G Laurent; F Huguet-Rigal
Journal:  Hematol Oncol       Date:  1984 Jul-Sep       Impact factor: 5.271

4.  Human gamma gamma-enolase: two-site immunoradiometric assay with a single monoclonal antibody.

Authors:  B S Soler-Federsppiel; P Cras; J Gheuens; D Andries; A Lowenthal
Journal:  J Neurochem       Date:  1987-01       Impact factor: 5.372

5.  Neuron-specific enolase is produced by neuroendocrine tumours.

Authors:  F J Tapia; J M Polak; A J Barbosa; S R Bloom; P J Marangos; C Dermody; A G Pearse
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

6.  [Contribution of immunohistochemical methods to the study of central nervous system tumors].

Authors:  L J Rubinstein
Journal:  Ann Pathol       Date:  1986       Impact factor: 0.407

7.  Electron-immunocytochemical localization of neuron-specific enolase in cytoplasm and on membranes of primary and metastatic cerebral tumours and on glial filaments of glioma cells.

Authors:  S A Vinores; M M Herman; L J Rubinstein
Journal:  Histopathology       Date:  1986-09       Impact factor: 5.087

8.  Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues.

Authors:  S A Vinores; J M Bonnin; L J Rubinstein; P J Marangos
Journal:  Arch Pathol Lab Med       Date:  1984-07       Impact factor: 5.534

9.  Distribution of neurofilament protein and neuron-specific enolase in peripheral neuronal tumours.

Authors:  A Sasaki; A Ogawa; Y Nakazato; Y Ishida
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Small cell neuroendocrine carcinoma of the colon and rectum: clinical, histologic, and ultrastructural study and immunohistochemical comparison with cloacogenic carcinoma.

Authors:  M R Wick; R P Weatherby; L H Weiland
Journal:  Hum Pathol       Date:  1987-01       Impact factor: 3.466
View more
  7 in total

1.  Langerhans cells can express neuron-specific enolase immunoreactivity.

Authors:  F Fantini; C Pincelli; C Sevignani; A Baraldi; A Giannetti
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

Review 2.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.

Authors:  Liang Wang; Panpan Liu; Xiaoqin Chen; Qirong Geng; Yue Lu
Journal:  Med Oncol       Date:  2011-08-30       Impact factor: 3.064

4.  Immunocytochemistry in adrenocortical tumours: a clinicomorphological study of 72 neoplasms.

Authors:  S Schröder; B C Padberg; E Achilles; K Holl; H Dralle; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

5.  Serum neuron-specific enolase levels are upregulated in patients with acute lymphoblastic leukemia and are predictive of prognosis.

Authors:  Cheng-Cheng Liu; Hua Wang; Jing-Hua Wang; Liang Wang; Qi-Rong Geng; Xiao-Qin Chen; Yue Lu
Journal:  Oncotarget       Date:  2016-08-23

6.  A Missing Link between Neuron Specific Enolase Release and Poor Prognosis in Aging Patients with B-cell Lymphoma.

Authors:  Rachel Polcyn; Jason God; Mollie Capone; Denise Matzelle; Naren L Banik; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2018-05-15

7.  NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy.

Authors:  Jianbo Li; Hongman Zhang; Min Xie; Lingfei Yan; Jiawei Chen; Hongxing Wang
Journal:  Diabetes Care       Date:  2013-07-11       Impact factor: 19.112
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.